Comparison of two systemic steroid regimens for the treatment of COPD exacerbations
Articles > Article · 2013
Authors: Yelda ÇEVİKER, Abdullah SAYINER
Pulmonary Pharmacology & Therapeutics, Journal Indexed in SCI Expanded, International, WoS, 2013, vol 27, pp 179-183
DOI: 10.1016/j.pupt.2013.03.004
Summary
Rationale: Systemic steroids shorten recovery time, improve lung function and hypoxemia in COPD exacerbations. Although several studies have shown that both parenteral and oral steroids are effective and GOLD guideline recommends use of oral steroids at a dose of 30-40 mg/day, very little data exists as to whether any route of admininstration (parenteral vs oral) or any dose is more effective and/or safer.